HISKY MED is headquartered in Wuxi, China. It has 2 R&D centers in Wuxi and Beijing respectively. Its self-developed non-invasive liver fibrosis diagnostic system, FibroTouch,is capable of making quantitative detection and assessment of liver fibrosis and hepatic steatosis with low frequency shear wave technology. Today, FibroTouch has been widely used in screening, diagnosis, monitoring and follow-up before, duringand aftertreatment for patients with liverproblems.It hasgreatly contributed to early detection, early prevention of liver diseases and thus enabling the early treatment of chronic liver diseases.
Currently, HISKY MED offers a wide range of specialized, sophisticated while economical liver diagnostic systems that address the needs of different niches of customers worldwide. With the new solution developed based on Transient Elastography (TE) technology, HISKY MED will continues to develop new products to positively influence the future of non-invasive liver diagnosis in the medical industry.